To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease
Clinical trial NCT04747977 · COMPLETED
Trial details
- NCT number
- NCT04747977
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-12
- Primary completion
- 2021-08-11
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.